An Unusual Case Report of Kounis Syndrome Following Cystoscopy
Keywords:
Kounis syndrome, anaphylaxis, hypersensitivity, cystoscopy, acute coronary syndromeAbstract
Background: Kounis syndrome is an acute coronary syndrome that can occur in the context of hypersensitivity reactions. It typically occurs in middle-aged to elderly patients, especially in males. Additional risk factors may include a history of atopy, smoking, hypertension, diabetes mellitus, and dyslipidemia. It is classified into type I (vasospasm in a normal coronary vessel), type II (rupture or vasospasm in a pre-existing atheromatous plaque), type III (stent thrombosis or restenosis), and type IV (coronary artery bypass graft thrombosis). A variable combination of features suggestive of allergy (rash, pruritus, wheezing) and cardiac ischemia (chest pain, arrhythmias, heart failure) may be observed, guiding management.
The Case: A 73-year-old male presented to the Emergency Department (ED) with chest pain, pruritic rash, dizziness, diaphoresis, and hypotension shortly after cystoscopy. The rash consisted of plaques over the trunk and extremities. His past medical history was notable for previous smoking, hyperlipidemia, hypertension, acute coronary syndrome treated with a stent in the left circumflex (LCX) artery 17 years ago, benign prostatic hyperplasia, and bladder cancer for which he had multiple surveillance cystoscopies. The patient denied any allergies. Previous medications were aspirin, atorvastatin, nebivolol, ranolazine, olmesartan, hydrochlorothiazide, and tamsulosin. Coronary angiography following a positive single-photon emission computed tomography (SPECT) six years ago revealed a patent stent, left anterior descending (LAD) blockage, and insignificant stenoses in the following arteries: left main (LM), first diagonal branch (DG1), LCX, first obtuse coronary artery (OM1), and right coronary artery (RCA). Laboratory testing in the ED revealed elevated D-dimers and troponin on repeat testing; further assessment with electrocardiogram (ECG), echocardiogram (ejection fraction 60%), chest X-ray (CXR), and computed tomography pulmonary angiography (CTPA) was unremarkable, consistent with non-ST-segment elevation myocardial infarction (NSTEMI). Given the dominant manifestation of the allergic reaction, initial management included intravenous fluids, methylprednisolone, and dimetindene, leading to the rapid resolution of his symptoms. During his hospitalization, methylprednisolone, levosetirizine, and inhaled ipratropium/budesonide were added to the medication regimen while the patient remained clinically stable with normalizing troponin levels. Coronary angiography was unchanged three days after the event. Hence, the combination of cardiac ischemia and pruritic rash, the rapid response to antiallergic medications, and normal coronary angiography pointed to the diagnosis of Kounis syndrome. The patient was discharged with prescriptions for aspirin, clopidogrel, esomeprazole, ranolazine, nebivolol, tamsulosin, rosuvastatin, ezetimibe, and a 3-day regimen of levosetirizine. Follow-up echocardiography after 1 week was unchanged with a similar ejection fraction, normal ventricular diameters, diastolic dysfunction, moderate left atrial dilation, and a small pericardial effusion.
Conclusion: Kounis syndrome should be suspected in patients with features suggestive of anaphylaxis (pruritic rash and hypotension) as well as myocardial ischemia (chest pain, diaphoresis, and elevated troponin), especially in patients with cardiovascular risk factors. This case emphasizes that cystoscopy represents an unusual cause of severe hypersensitivity reactions. Potential triggers include antiseptics, anesthetics, neuromuscular blocking agents, antibiotics, and latex, which may not be identified.
References
1) Dai B, Cavaye J, Judd M, Beuth J, Iswariah H, Gurunathan U. Perioperative Presentations of Kounis Syndrome: A Systematic Literature Review. J Cardiothorac Vasc Anesth. 2022;36(7):2070-2076. doi:10.1053/j.jvca.2022.01.042
2) Lee T, Sanderson D, Doyle P, Buchsbaum G. Anaphylactic Shock After Intravenous Fluorescein Administration for Intraoperative Cystoscopy. Obstet Gynecol. 2018;131(4):727-729. doi:10.1097/AOG.0000000000002519
3) Laguna JJ, Archilla J, Doña I, et al. Practical Guidelines for Perioperative Hypersensitivity Reactions. J Investig Allergol Clin Immunol. 2018;28(4):216-232. doi:10.18176/jiaci.0236
4) Ewan PW, Dugué P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010;40(1):15-31. doi:10.1111/j.1365-2222.2009.03404.x
5) Rochel-Perez E, Santaularia-Tomas M, Martin-Dorantes M, et al. Triggers, Types, and Treatments for Kounis Syndrome: A Systematic Review. Clin Pract. 2025;15(3):59. Published 2025 Mar 13. doi:10.3390/clinpract15030059
6) Kounis NG, Stefanidis A, Hung MY, et al. From Acute Carditis, Rheumatic Carditis, and Morphologic Cardiac Reactions to Allergic Angina, Allergic Myocardial Infarction, and Kounis Syndrome: A Multidisciplinary and Multisystem Disease. J Cardiovasc Dev Dis. 2025;12(9):325. Published 2025 Aug 25. doi:10.3390/jcdd12090325
7) Yakushin S, Gurbanova A, Pereverzeva K. Kounis Syndrome: Review of Clinical Cases. Cardiovasc Hematol Disord Drug Targets. 2024;24(2):83-97. doi:10.2174/011871529X305833240708051508
8) Leivaditis V, Chatzigrigoriadis C, Koletsis E, Mplani V, Dousdampanis P, Mulita F, Kounis NG, Assimakopoulos SF. Kounis Syndrome in Cardiac Surgery: Pathophysiology, Antimicrobial Triggers, and Perioperative Recognition and Management. Medical Sciences. 2026; 14(2):207. https://doi.org/10.3390/medsci14020207
9) Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med. 2016;54(10):1545-1559. doi:10.1515/cclm-2016-0010
10) Ma M, Duncan D, Bartoszko J. Perioperative anaphylaxis: an update on pathophysiology, diagnosis, and management. Anaphylaxie périopératoire : mise à jour sur la physiopathologie, le diagnostic et la prise en charge. Can J Anaesth. 2025;72(4):649-674. doi:10.1007/s12630-025-02915-5
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Georgios Boliaris, Theodoros Fliskanopoulos, Christodoulos Chatzigrigoriadis, Georgios Eleftherakis

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org



